Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage

Vaccine

Volumn 29, Issue 10, 2011, Pages 1959-1967

  Prymula, Roman ^a   Hanovcova, Irena ^a   Splino, Miroslav ^a   Kriz, Pavla ^b   Motlova, Jitka ^b   Lebedova, Vera ^b   Lommel, Patricia ^d   Kaliskova, Eva ^c   Pascal, Thierry ^d   Borys, Dorota ^d   Schuerman, Lode ^d  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^c GLAXOSMITHKLINE   (United Kingdom)

^d GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Booster; Haemophilus influenzae; Nasopharyngeal carriage; Streptococcus pneumoniae; Vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE D PNEUMOCOCCAL VACCINE; HAEMOPHILUS INFLUENZAE VACCINE; PARACETAMOL; PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ARTICLE; CHILD; CLINICAL ASSESSMENT; DRUG EFFICACY; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS INFLUENZAE INFECTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; NASOPHARYNX; OPEN STUDY; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

CARRIER STATE; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; IMMUNIZATION, SECONDARY; INFANT; MALE; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 79951725108     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.12.086     Document Type: Article

References (40)

1. Klugman K.P. Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance. Lancet Infect Dis 2001, 1:85-91.
2. Nurkka A., Ahman H., Yaich M., Eskola J., Käyhty H. Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT. Vaccine 2001, 20:194-201.
3. Nurkka A., Ahman H., Korkeila M., Jäntti V., Käyhty H., Eskola J. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2001, 20:25-33.
4. O'Brien K.L., Dagan R. The potential indirect effect of conjugate pneumococcal vaccines. Vaccine 2003, 21(17-18):1815-1825.
5. Murphy T.F. Respiratory infections caused by non-typeable Haemophilus influenzae. Curr Opin Infect Dis 2003, 16:129-134.
6. Watanabe H., Hoshino K., Sugita R., Asoh N., Watanabe K., Oishi K., et al. Possible high rate of transmission of nontypeable Haemophilus influenzae, including beta-lactamase-negative ampicillin-resistant strains, between children and their parents. J Clin Microbiol 2004, 42:362-365.
7. Abdullahi O., Nyiro J., Lewa P., Slack M., Scott J.A. The descriptive epidemiology of Streptococcus pneumoniae and Haemophilus influenzae nasopharyngeal carriage in children and adults in Kilifi district, Kenya. Pediatr Infect Dis J 2008, 27:59-64.
8. Jokinen J.T., Åhman H., Kilpi T.M., Mäkelä P.H., Käyhty M.H. Concentration of anti pneumococcal antibodies as a serological correlate of protection: an application to acute otitis media. J Infect Dis 2004, 190:545-550.
9. Dagan R., Givon-Lavi N., Fraser D., Lipsitch M., Siber G.R., Kohberger R. Serum serotype-specific pneumococcal anticapsular immunoglobulin G concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus. J Infect Dis 2005, 192:367-376.
10. Millar E.V., O'Brien K.L., Bronsdon M.A., Madore D., Hackell J.G., Reid R., et al. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine. Clin Infect Dis 2007, 44:1173-1179.
11. Zhang Z., Clarke T.B., Weiser J.N. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 2009, 119(7):1899-1909.
12. Syrjänen R.K., Auranen K.J., Leino T.M., Kilpi T.M., Mäkelä P.H. Pneumococcal acute otitis media in relation to pneumococcal nasopharyngeal carriage. Pediatr Infect Dis J 2005, 24:801-806.
13. Gray B.M., Converse G.M., Dillon H.C. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980, 142:923-933.
14. Sethi S., Evans N., Grant B.J., Murphy T.F. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002, 347:465-471.
15. Syrjänen R.K., Herva E.E., Mäkelä P.H., Puhakka H.J., Auranen K.J., Takala A.K., et al. The value of nasopharyngeal culture in predicting the etiology of acute otitis media in children less than two years of age. Pediatr Infect Dis J 2006, 25:1032-1036.
16. Eldan M., Leibovitz E., Piglansky L., Raiz S., Press J., Yagupsky P., et al. Predictive value of pneumococcal nasopharyngeal cultures for the assessment of nonresponsive acute otitis media in children. Pediatr Infect Dis J 2000, 19:298-303.
17. Leiberman A., Dagan R., Leibovitz E., Yagupsky P., Fliss D.M. The bacteriology of the nasopharynx in childhood. Int J Pediatr Otorhinolaryngol 1999, 49:S151-S153.
18. Gehanno P., Barry B., Berche P. Acute childhood otitis media: the diagnostic value of bacterial samples from the nasopharynx. Clin Microbiol Infect 1997, 3:S34-S36.
19. O'Brien K.L., Millar E.V., Zell E.R., Bronsdon M., Weatherholtz R., Reid R., et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis 2007, 196:1211-1220.
20. Millar E.V., Watt J.P., Bronsdon M.A., Dallas J., Reid R., Santosham M., et al. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members. Clin Infect Dis 2008, 47:989-996.
21. Prymula R., Peeters P., Chrobok V., Kriz P., Novakova E., Kaliskova E., et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 2006, 367:740-748.
22. Mbelle N., Huebner R.E., Wasas A.D., Kimura A., Chang I., Klugman K.P. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis 1999, 180:1171-1176.
23. Prymula R., Kriz P., Kaliskova E., Pascal T., Poolman J., Schuerman L. Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age. Vaccine 2009, 28:71-78.
24. Song X.M., Forsgren A., Janson H. The gene encoding protein D (hpd) is highly conserved among Haemophilus influenzae type b and nontypeable strains. Infect Immun 1995, 63:696-699.
25. Janson H., Ruan M., Forsgren A. Limited diversity of the protein D gene (hpd) among encapsulated and nonencapsulated Haemophilus influenzae strains. Infect Immun 1993, 61:4546-4552.
26. Prymula R., Siegrist C.A., Chlibek R., Zemlickova H., Vackova M., Smetana J., et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet 2009, 374:1339-1350.
27. Manual of clinical microbiology 1995, American Society of Microbiology, Washington DC. Sixth ed. P.R. Murray (Ed.).
28. Murphy T.F., Brauer A.L., Sethi S., Kilian M., Cai X., Lesse A.J. Haemophilus haemolyticus: A human respiratory tract commensal to be distinguished from Haemophilus influenzae. J Infect Dis 2007, 195:81-89.
29. McCrea K.W., Xie J., LaCross N., Patel M., Mukundan D., Murphy T.F., et al. Relationships of nontypeable Haemophilus influenzae strains to hemolytic and nonhemolytic Haemophilus haemolyticus strains. J Clin Microbiol 2008, 46:406-416.
30. Nelson M.B., Munson R.S., Apicella M.A., Sikkema D.J., Molleston J.P., Murphy T.F. Molecular conservation of the P6 outer membrane protein among strains of Haemophilus influenzae: analysis of antigenic determinants, gene sequences, and restriction fragment length polymorphisms. Infect Immun 1991, 59:2658-2663.
31. Obaro S.K., Adegbola R.A., Banya W.A., Greenwood B.M. Carriage of pneumococci after pneumococcal vaccination. Lancet 1996, 348:271-272.
32. Dagan R., Givon-Lavi N., Zamir O., Sikuler-Cohen M., Guy L., Janco J., et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis 2002, 185:927-936.
33. Kilpi T.M., Syrjänen R., Palmu A., Herva E., Eskola J., Mäkelä P.H., et al. Parallel evaluation of the effect of a 7-valent pneumococcal conjugate vaccine (PNCCRM) on pneumococcal (PNC) carriage and acute otitis media (AOM). 19th Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID 2001) 2001.
34. Ghaffar F., Barton T., Lozano J., Muniz L.S., Hicks P., Gan V., et al. Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life. Clin Infect Dis 2004, 39:930-938.
35. Kilpi T., Ahman H., Jokinen J., Lankinen K.S., Palmu A., Savolainen H., et al. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis 2003, 37:1155-1164.
36. Eskola J., Kilpi T., Palmu A., Jokinen J., Haapakoski J., Herva E., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001, 344:403-409.
37. McEllistrem M.C., Adams J., Mason E.O., Wald E.R. Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. J Infect Dis 2003, 188:1679-1684.
38. Cheung Y.B., Zaman S.M., Nsekpong E.D., Van Beneden C.A., Adegbola R.A., Greenwood B., et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings. Pediatr Infect Dis J 2009, 28:990-995.
39. van Gils E.J., Veenhoven R.H., Hak E., Rodenburg G.D., Bogaert D., Ijzerman E.P., et al. Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial. JAMA 2009, 302:159-167.
40. Van Effelterre T., Moore M.R., Fierens F., Whitney C.G., White L., Pelton S.I., et al. A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination. Vaccine 2010, 28(21):3650-3660.